DSRU Observational Studies on the COVID19 vaccines
16 July 2021
Recruitment of participants is almost complete for our post-authorisation study to monitor the safety of the AstraZeneca COVID-19 vaccine. The study uses active surveillance methodology, meaning that we actively recruit patients at or before vaccination and remind them at intervals to inform us of any symptoms they have following vaccination.
The DSRU is also involved in European collaborative studies on the Pfizer, Moderna and AstraZeneca COVID-19 vaccines, with more studies on other COVID vaccines and treatments in the pipeline. For some of these studies, the DSRU conducts studies on the CPRD database, while others involve collection of data from NHS patients or prescribers.
The DSRU is undertaking the UK arm of the COVID Vaccine Monitor study, a European study which monitors for side effects of all COVID vaccines, led by the Dutch national pharmacovigilance centre, Lareb. Further information on this study is available here: https://covidvaccinemonitor.co.uk/